Verastem (VSTM) Invested Capital (2011 - 2026)
Verastem (VSTM) recorded quarterly Invested Capital of $81.8 million in Q1 2026, up 42.97% quarter-over-quarter from $57.2 million in Q4 2025, and up 352.14% on a YoY basis from $18.1 million in Q1 2025.
Verastem (VSTM) Invested Capital (2011 - 2026) Analysis & Trends
Verastem's Invested Capital history runs 16 years deep, the most recent figure standing at $81.8 million for Q1 2026.
- In Q1 2026, Invested Capital rose 352.14% year-over-year to $81.8 million; the TTM figure through Mar 2026 stood at $81.8 million (up 352.14% YoY), while the FY2025 annual figure was $57.2 million, up 297.96% from the prior year.
- Invested Capital was $81.8 million for Q1 2026 at Verastem, up from $57.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $101.6 million in Q2 2023 to a low of -$32.4 million in Q1 2025.
- Historically, Invested Capital has averaged $40.0 million across 5 years, with a median of $47.4 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Invested Capital tumbled 229.41% in 2025, then soared 352.14% in 2026.
- A 5-year view of Invested Capital shows it stood at $47.4 million in 2022, then advanced by 21.07% to $57.4 million in 2023, then sank by 150.36% to -$28.9 million in 2024, then jumped by 297.96% to $57.2 million in 2025, then surged by 42.97% to $81.8 million in 2026.
- The last three Invested Capital figures came in at $81.8 million (Q1 2026), $57.2 million (Q4 2025), and -$15.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 81.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.78 Mn |
| Dec 31, 2025 | 57.20 Mn |
| Sep 30, 2025 | -15.53 Mn |
| Jun 30, 2025 | 36.06 Mn |
| Mar 31, 2025 | -32.43 Mn |
| Dec 31, 2024 | -28.89 Mn |
| Sep 30, 2024 | 20.93 Mn |
| Jun 30, 2024 | 23.78 Mn |
| Mar 31, 2024 | 25.06 Mn |
| Dec 31, 2023 | 57.37 Mn |
| Sep 30, 2023 | 83.18 Mn |
| Jun 30, 2023 | 101.59 Mn |
| Mar 31, 2023 | 33.03 Mn |
| Dec 31, 2022 | 47.39 Mn |
| Sep 30, 2022 | 62.87 Mn |
| Jun 30, 2022 | 53.89 Mn |
| Mar 31, 2022 | 72.77 Mn |
| Dec 31, 2021 | 87.56 Mn |
| Sep 30, 2021 | 95.66 Mn |
| Jun 30, 2021 | 88.21 Mn |